Cost Minimization Study between Intravenous Rituximab (R-IV) vs Subcutaneous Rituximab (R-SC) in Thai Patients with Diffused Large B-CELL Lymphoma (DLBCL): A Simulation of Electronic Health Record (E-HR) and Evidence Synthesis

Cost Minimization Study between Intravenous Rituximab (R-IV) vs Subcutaneous Rituximab (R-SC) in Thai Patients with Diffused Large B-CELL Lymphoma (DLBCL): A Simulation of Electronic Health Record (E-HR) and Evidence Synthesis

Saved in:
Bibliographic Details
Published in:Value in health Vol. 21; p. S108
Main Authors: Chansung, K, Sirijerachai, C, Teawtrakul, N
Format: Journal Article
Language:English
Published: 01-09-2018
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1098-3015
DOI:10.1016/j.jval.2018.07.825